The United States Medicines Agency (FDA) has met to discuss the third dose of Pfizer vaccine that is expected to be given to people 16 years of age and older.
For fear of myocarditis – an inflammation of the heart muscle – in male adolescents and adults, the committee voted against administering a third dose of Pfizer’s coronavirus vaccine (16 votes against – 2 votes in favor).
However, a vaccination booster for all Americans who have received their second dose in eight months provided the FDA approves.
– .
Related posts:
Cáritas denounces with the reading of a manifesto that the homeless are "out of coverage"
Royal Family Drama: Will Harry and Meghan be Invited to Sandringham Castle for Christmas?
Artist David Living on Castle-Shaped Raft on Garonne River: A Fantasy Movie Come to Life
Alena's horoscope: Gemini to be suspicious when dating, Crabs think how to make money
